Patents, Pharmaceutical
patent, grace period, priority, invention, entrepreneurs
patents, synthetic biology, Nagoya protocol, genetic resources, biodiversity
synthetic biology, plant genetic resources, access and benefit sharing, digital sequence information
CBD, biodiversity, digital sequence information, synthetic biology, patent, indigenous peoples, justice
patent, biodiversity, biotechnology stem cells, China, morality
compulsory licenses, access to medicines, commandments, Judeo-Christian, pharmaceuticals, patents
intellectual property, patents, grace period, technology transfer
Nagoya Protocol, Convention on Biological Diversity, patents, genetic resources, traditional knowledge, indigenous peoples and local communities, synthetic biology, digital sequence information
design, patent, WIPO, traditional knowledge, genetic resources, traditional cultural expressions, morality
patent, genetic, cultural, designs, WIPO, traditional
Religion, Christian, Muslim, Jewish, Scholarship, Inspiration, Patents and Copyrights, Intellectual Property: Other journal edited by Robert Merges, among other places
Promega, Life Technologies, inducement, 35 U.S.C. 271(f), 271(f), export, patent infringement, staple article of commerce, Taq-polymerase, extraterritorial, extraterritoriality, conflict of laws, comity